Osteoprotegerin Is more than a Possible Serum Marker in Liver Fibrosis: A Study into Its Function in Human and Murine Liver
Osteoprotegerin (OPG) serum levels are associated with liver fibrogenesis and have been proposed as a biomarker for diagnosis. However, the source and role of OPG in liver fibrosis are unknown, as is the question of whether OPG expression responds to treatment. Therefore, we aimed to elucidate the f...
Main Authors: | Adhyatmika Adhyatmika, Leonie Beljaars, Kurnia S. S. Putri, Habibie Habibie, Carian E. Boorsma, Catharina Reker-Smit, Theerut Luangmonkong, Burak Guney, Axel Haak, Keri A. Mangnus, Eduard Post, Klaas Poelstra, Kim Ravnskjaer, Peter Olinga, Barbro N. Melgert |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-05-01
|
Series: | Pharmaceutics |
Subjects: | |
Online Access: | https://www.mdpi.com/1999-4923/12/5/471 |
Similar Items
-
Osteoprotegerin Expression in Liver is Induced by IL13 through TGFβ
by: Adhyatmika, Adhyatmika, et al.
Published: (2022) -
Hepatoprotective Efficacy of Cycloastragenol Alleviated the Progression of Liver Fibrosis in Carbon-Tetrachloride-Treated Mice
by: Theerut Luangmonkong, et al.
Published: (2023-01-01) -
Pathogenetic and diagnostic role of osteoprotegerin in the combined course of osteoarthritis and obesity
by: A. Litvynova, et al.
Published: (2022-05-01) -
The effect of osteoprotegerin on implant osseointegration in ovariectomized rats
by: Yiming Liu, et al.
Published: (2017-01-01) -
Bone Alterations in Inflammatory Bowel Diseases: Role of Osteoprotegerin
by: Kateryna Priadko, et al.
Published: (2022-03-01)